Crystal Peak Investment Inc. 13D and 13G filings for LakeShore Biopharma Co., Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 09:08 am Unchanged | 2026-04-29 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2026-03-25 07:34 am Unchanged | 2026-03-24 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2026-02-05 07:42 am Unchanged | 2026-02-04 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2025-11-04 08:50 am Unchanged | 2025-11-04 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2025-10-29 08:05 am Unchanged | 2025-10-27 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2025-08-27 09:02 am Unchanged | 2025-08-26 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 0 (Unchanged) | Filing |
| 2025-07-22 08:57 am Purchase | 2025-07-08 | 13D | LAKESHORE BIOPHARMA CO LTD LSBCF | Crystal Peak Investment Inc. | 21,021,332 51.000% | 21,021,332 (New Position) | Filing |